Luciferin and Derivatives as a Dyrk Selective Scaffold for the Design of Protein Kinase Inhibitors.
Rothweiler, U., Eriksson, J., Stensen, W., Leeson, F., Engh, R.A., Svendsen, J.S.(2015) Eur J Med Chem 94: 140
- PubMed: 25768698 
- DOI: 10.1016/j.ejmech.2015.02.035
- Primary Citation of Related Structures:  
4D1X, 4D1Z - PubMed Abstract: 
D-Luciferin is widely used as a substrate in luciferase catalysed bioluminescence assays for in vitro studies. However, little is known about cross reactivity and potential interference of D-luciferin with other enzymes. We serendipitously found that firefly luciferin inhibited the CDK2/Cyclin A protein kinase ...